Iprivask Side Effects
Generic Name: desirudin
Note: This document contains side effect information about desirudin. Some of the dosage forms listed on this page may not apply to the brand name Iprivask.
For the Consumer
Applies to desirudin: parenteral powder for injection
Side effects include:
Hemorrhage, including hematoma, was most common adverse effect in clinical studies in patients undergoing elective total hip-replacement surgery.
For Healthcare Professionals
Applies to desirudin: subcutaneous powder for injection
The most common adverse reaction was hemorrhage.[Ref]
Very common (10% or more): Any hemorrhage (30%)
Common (1% to 10%): Serious hemorrhage, deep vein thrombosis
Uncommon (0.1% to 1%): Major hemorrhage
Frequency not reported: Thrombosis, hypotension
Postmarketing reports: Fatal hemorrhage[Ref]
Common (1% to 10%): Wound secretion
Common (1% to 10%): Nausea
Common (1% to 10%): Anemia
Frequency not reported: Hemoglobin decreased[Ref]
Common (1% to 10%): Irritative skin reactions[Ref]
Common (1% to 10%): Injection site mass[Ref]
Frequency not reported: Allergic reaction, anti-hirudin antibodies
Postmarketing reports: Anaphylactic/anaphylactoid reaction[Ref]
Frequency not reported: Epistaxis[Ref]
1. "Product Information. Ipravask (desirudin)." Aventis Pharmaceuticals, Swiftwater, PA.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.